Second Quarter Revenue Increased 7.8% to $52
Million Compared to Same Period Last Year
LifeVantage Corporation (NASDAQ:LFVN) today reported financial
results for its second quarter ended December 31, 2015.
Second Quarter Fiscal 2016 Highlights:
- Revenue increased 14.6% to $52 million on a sequential basis
and increased 7.8% compared to second fiscal quarter of 2015;
- Revenue in the Americas increased 15.3% and revenue in
Asia/Pacific increased 12.4% on a sequential basis, including a
7.3% sequential revenue increase in Japan;
- Adjusted EBITDA increased 7.3% to $4.5 million, compared to
$4.2 million in the second fiscal quarter of 2015;
- Net income was $1.6 million which includes approximately $0.5
million of pretax one-time charges
- Executed on strategic growth plan including investments in new
product launches and enhanced distributor technology
platforms.
“We are pleased to report revenue growth on both
a sequential and year-over-year basis, which underscores the early
success of our growth plan and gives us confidence that our
business is on a path to deliver long-term and sustainable improved
financial performance,” stated LifeVantage President and Chief
Executive Officer Darren Jensen. “In the second quarter, we made
meaningful progress on our critical growth initiatives to expand
our product portfolio with the launch of PhysIQ™ Smart Weight
Management System, marking our entry into the estimated $148
billion worldwide weight management market. While it is still in
its very early stages, we have been encouraged by the strong
consumer and distributor responses to our newest product offerings.
In addition, we expanded our skincare product offering with the
launch of True Science™ Micro Lift Serum in the second
quarter.”
Mr. Jensen concluded, “We continue to make
progress across all aspects of our growth plan, including
investments in distributor leadership development, mobile
technology with the introduction of new business building
technologies, new products, brand development, and international
expansion. Our strategic plan focuses on changing the revenue
trends to a positive trajectory and we are pleased that revenue is
responding to these investments. Nevertheless, these investments
will impact our operating income results in the near-term.
However, we are confident that investing in our future growth will
better position our company to capitalize on opportunities ahead
and achieve accelerated sales growth.”
Second Quarter Fiscal 2016 Results
For the second fiscal quarter ended December 31,
2015, the Company reported revenue of $52 million, a 14.6% increase
compared sequentially to revenue of $45.4 million for the first
fiscal quarter ended September 30, 2015, and a 7.8% increase
compared to $48.2 million for the comparable period in fiscal 2015.
Year-over-year quarterly revenue reflects an increase of 14.3% in
the Americas and a decrease in the Asia/Pacific region of
9.6%. Revenue for the quarter was negatively impacted by $0.9
million, or approximately 1.9%, by foreign currency
fluctuation.
Commissions and incentives expense for the
second fiscal quarter of 2016 was $27.3 million, or 52.5% of
revenue, compared to $23.2 million, or 48.1% of revenue, in the
same period last year. Selling, general and administrative expense
(SG&A) for the second fiscal quarter of 2016 was $13.8 million,
or 26.6% of revenue, compared to $14.5 million, or 30% of revenue,
in the same period last year.
Second fiscal quarter of 2016 SG&A expenses
include costs associated with new product launches, initiatives to
enhance business building technology, and other strategic
investments to position the Company for future growth.
Furthermore, SG&A includes $0.5 million of pre-tax one-time
expenses; consisting of $0.4 million in executive team transition
costs, and $0.1 million in expenses associated with the Company’s
reverse stock split.
Operating income for the second fiscal quarter
of 2016 was $3 million, compared to $3.1 million for the second
fiscal quarter of 2015. This includes the aforementioned
investments to drive future sales and profit growth along with the
previously mentioned one-time expenses.
Adjusted EBITDA was $4.5 million for the second
fiscal quarter of 2016, compared to $4.5 million for the first
fiscal quarter of 2016 and $4.2 million for the prior year
period.
Net income for the second fiscal quarter of 2016
was $1.6 million, or $0.11 per diluted share, calculated on 14
million fully diluted shares. This compares to net income for
the second fiscal quarter of 2015 of $1.5 million, or $0.10 per
diluted share, calculated on 14.4 million fully diluted
shares. On a tax adjusted basis the previously mentioned
one-time charges were $0.3 million for the quarter resulting in
adjusted net income of $1.9 million for the second fiscal quarter
of 2016, or $0.14 per diluted share, compared to $1.5 million, or
$0.10 per diluted share in the comparable period last year.
Fiscal 2016 First Six Months Results
For the six months ended December 31, 2015, the Company reported
net revenue of $97.3 million, compared to $99.9 million in the
prior year period. Revenue in the Americas increased 4.6%, while
revenue in Asia/Pacific decreased 20.5% due primarily to lower
sales in Japan. Revenue for the first six months of fiscal 2016 was
negatively impacted $2.8 million, or 2.8%, by foreign currency
fluctuation.
Operating income for the first six months of fiscal 2016 was
$5.7 million, compared to $10.9 million in the prior year period.
Operating income for the six months ended December 31, 2015
includes $1.6 million of the previously mentioned one-time
expenses. Adjusted EBITDA was $8.9 million for the first six months
of fiscal 2016, compared to $11 million in the prior year. First
six months fiscal 2015 operating income and Adjusted EBITDA include
the benefit of approximately $2 million from proceeds recovered and
related to the Company's December 2012 product recall.
Net income for the first six months of fiscal
2016 was $2.7 million, or $0.19 per diluted share, compared to $6.2
million, or $0.43 per diluted share in the prior year period. On a
tax adjusted basis the previously mentioned one-time charges were
$1 million for the first six months of fiscal 2016 resulting in
adjusted net income of $3.7 million or $0.27 per diluted
share. On a tax adjusted basis the one-time insurance benefit
for the first six months of fiscal 2015 was $1.3 million, resulting
in adjusted net income of $4.8 million or $0.34 per diluted
share.
Balance Sheet & Liquidity
The Company generated $8.5 million of cash flow
from operations in the first six months of fiscal 2016, compared to
$8 million in the same period last year. The Company's cash
and cash equivalents at December 31, 2015 were $15.8 million
compared to $13.9 million at the end of fiscal year 2015. The
Company repaid $6.8 million of debt during the first six months of
fiscal 2016.
Fiscal Year 2016 Guidance
The Company is updating its fiscal year 2016 annual guidance.
The Company continues to expect to generate revenue in the range of
$195 million to $210 million in fiscal year 2016. On an adjusted
non-GAAP earnings per diluted share basis, excluding certain
one-time costs, the Company expects to achieve the range of $0.50
to $0.60.
Based on the previously mentioned one-time expenses, the Company
now expects GAAP earnings per diluted share in the range of $0.42
to $0.52 compared to the previous range of $0.56 to $0.77, based on
an estimated 14.0 million diluted shares and a 36% effective tax
rate.
Conference Call Information
The Company will hold an investor conference
call today at 2:30 p.m. Mountain time (4:30 p.m. Eastern time).
Investors interested in participating in the live call can dial
(888) 215-6917 from the U.S. International callers can dial
(913) 905-1087. A telephone replay will be available
approximately two hours after the call concludes and will be
available through Tuesday, February 16, 2016, by dialing (877)
870-5176 from the U.S. and entering confirmation code 6715410, or
(858) 384-5517 from international locations, and entering
confirmation code 6715410.
There will also be a simultaneous, live webcast
available on the Investor Relations section of the Company's web
site at http://investor.lifevantage.com/events.cfm. The webcast
will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science based
network marketing company dedicated to visionary science that looks
to transform health, wellness and anti-aging internally and
externally at the cellular level. The company is the maker of
Protandim®, the Nrf2 Synergizer® patented dietary supplement, the
TrueScience™ Anti-Aging Skin Care Regimen, Canine Health, the AXIO™
energy product line and the PhysIQ™ smart weight management system.
LifeVantage was founded in 2003 and is headquartered in Salt Lake
City, Utah.
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe", "objectives", "hopes", "intends",
"estimates", "expects", "projects", "plans", "anticipates", "look
forward to", "executing our growth plan", "path to deliver
long-term growth", and variations thereof, identify forward-looking
statements, but their absence does not mean that a statement is not
forward-looking. Examples of forward looking statements include,
but are not limited to, statements we make regarding our leadership
in the global market, product and country expansion, and future
growth and financial performance. Such forward-looking statements
are not guarantees of performance and the Company's actual results
could differ materially from those contained in such statements.
These forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, those discussed in greater
detail in the Company's Annual Report on Form 10-K and the
Company's Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to
time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
About Non-GAAP Financial Measures
We define Non-GAAP EBITDA as earnings before interest expense,
income taxes, depreciation and amortization and Non-GAAP Adjusted
EBITDA as earnings before interest expense, income taxes,
depreciation and amortization, stock compensation expense, other
income, net, and certain other adjustments. Non-GAAP EBITDA and
Non-GAAP Adjusted EBITDA may not be comparable to similarly titled
measures reported by other companies. We define Non-GAAP Net
Income and Earnings Per Share as GAAP net income less certain tax
adjusted non-recurring one-time expenses incurred during the
period.
We are presenting Non-GAAP EBITDA, Non-GAAP Adjusted EBITDA,
Non-GAAP Net Income and Non-GAAP Earnings Per Share because
management believes that they provide additional ways to view our
operations when considered with both our GAAP results and the
reconciliation to net income, which we believe provides a more
complete understanding of our business than could be obtained
absent this disclosure. Non-GAAP EBITDA, Non-GAAP Adjusted EBITDA,
Non-GAAP Net Income and Non-GAAP Earnings Per Share are presented
solely as a supplemental disclosure because: (i) we believe it is a
useful tool for investors to assess the operating performance of
the business without the effect of these items; (ii) we believe
that investors will find this data useful in assessing shareholder
value; and (iii) we use Non-GAAP EBITDA, Non-GAAP Adjusted EBITDA,
Non-GAAP Net Income and Non-GAAP Earnings Per Share internally as a
benchmark to evaluate our operating performance or compare our
performance to that of our competitors. The use of Non-GAAP EBITDA,
Non-GAAP Adjusted EBITDA, Non-GAAP Net Income and Non-GAAP Earnings
Per Share has limitations and you should not consider these
measures in isolation from or as an alternative to the relevant
GAAP measure of net income prepared in accordance with GAAP, or as
a measure of profitability or liquidity.
The tables set forth below present Non-GAAP EBITDA, Non-GAAP
Adjusted EBITDA, Non-GAAP Net Income and Non-GAAP Earnings Per
Share which are non-GAAP financial measures to Net Income and
Earnings Per Share, our most directly comparable financial measures
presented in accordance with GAAP.
LIFEVANTAGE CORPORATION AND
SUBSIDIARIES |
|
CONSOLIDATED BALANCE SHEETS |
|
(unaudited) |
|
|
|
|
|
|
|
(In
thousands, except per share data) |
As of, |
|
ASSETS |
December 31, 2015 |
|
June 30, 2015 |
|
Current assets |
|
|
|
|
|
Cash and cash equivalents |
$ |
15,819 |
|
|
$ |
13,905 |
|
|
|
Accounts receivable |
|
1,738 |
|
|
|
1,031 |
|
|
|
Income tax receivable |
|
2,205 |
|
|
|
2,179 |
|
|
|
Inventory |
|
10,619 |
|
|
|
9,248 |
|
|
|
Current deferred income tax
asset |
|
1,086 |
|
|
|
1,117 |
|
|
|
Prepaid expenses and deposits |
|
5,016 |
|
|
|
2,995 |
|
|
|
Total current assets |
|
36,483 |
|
|
|
30,475 |
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
5,180 |
|
|
|
5,759 |
|
|
|
Intangible assets, net |
|
1,812 |
|
|
|
1,879 |
|
|
|
Long-term deferred income tax
asset |
|
229 |
|
|
|
235 |
|
|
|
Other long-term assets |
|
1,223 |
|
|
|
1,433 |
|
|
TOTAL
ASSETS |
$ |
44,927 |
|
|
$ |
39,781 |
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY |
|
|
|
|
Current
liabilities |
|
|
|
|
|
Accounts payable |
$ |
5,857 |
|
|
$ |
2,614 |
|
|
|
Commissions payable |
|
7,733 |
|
|
|
6,505 |
|
|
|
Other accrued expenses |
|
9,005 |
|
|
|
5,600 |
|
|
|
Current portion of long-term
debt |
|
12,229 |
|
|
|
11,141 |
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
34,824 |
|
|
|
25,860 |
|
|
|
|
|
|
|
|
Long-term
debt |
|
|
|
|
|
Principal amount |
|
2,583 |
|
|
|
10,484 |
|
|
|
Less: unamortized discount and
deferred offering costs |
|
(1,544 |
) |
|
|
(1,951 |
) |
|
|
Long-term debt, net of unamortized
discount and deferred offering costs |
|
1,039 |
|
|
|
8,533 |
|
|
|
Other long-term liabilities |
|
2,055 |
|
|
|
2,063 |
|
|
|
Total liabilities |
|
37,918 |
|
|
|
36,456 |
|
|
Commitments
and contingencies - Note 6 |
|
|
|
|
Stockholders' equity |
|
|
|
|
|
Preferred stock - par value $.001
per share, 50,000 shares authorized; no shares issued or
outstanding |
|
- |
|
|
|
- |
|
|
|
Common stock - par value $.001 per
share, 250,000 shares authorized and 13,992 and 13,958 issued and
outstanding as of December 31, 2015 and June 30, 2015,
respectively |
|
14 |
|
|
|
14 |
|
|
|
Additional paid-in capital |
|
118,649 |
|
|
|
117,657 |
|
|
|
Accumulated deficit |
|
(111,429 |
) |
|
|
(114,095 |
) |
|
|
Accumulated other comprehensive
loss |
|
(225 |
) |
|
|
(251 |
) |
|
|
Total stockholders’ equity |
|
7,009 |
|
|
|
3,325 |
|
|
TOTAL
LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ |
44,927 |
|
|
$ |
39,781 |
|
|
|
|
|
|
|
|
LIFEVANTAGE CORPORATION AND
SUBSIDIARIES |
CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME |
(unaudited) |
|
|
|
|
|
|
|
|
|
For the Three Months Ended December
31, |
|
For the Six Months Ended December
31, |
|
|
2015 |
|
|
|
2014 |
|
|
|
2015 |
|
|
|
2014 |
|
(In thousands, except
per share data) |
|
|
|
|
|
|
|
Revenue, net |
$ |
51,995 |
|
|
$ |
48,247 |
|
|
$ |
97,347 |
|
|
$ |
99,880 |
|
Cost of sales |
|
7,842 |
|
|
|
7,486 |
|
|
|
14,817 |
|
|
|
13,165 |
|
Gross profit |
|
44,153 |
|
|
|
40,761 |
|
|
|
82,530 |
|
|
|
86,715 |
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
Commissions and incentives |
|
27,297 |
|
|
|
23,195 |
|
|
|
49,340 |
|
|
|
47,769 |
|
Selling, general and
administrative |
|
13,824 |
|
|
|
14,476 |
|
|
|
27,487 |
|
|
|
28,091 |
|
Total operating expenses |
|
41,121 |
|
|
|
37,671 |
|
|
|
76,827 |
|
|
|
75,860 |
|
Operating income |
|
3,032 |
|
|
|
3,090 |
|
|
|
5,703 |
|
|
|
10,855 |
|
|
|
|
|
|
|
|
|
Other income
(expense): |
|
|
|
|
|
|
|
Interest expense |
|
(619 |
) |
|
|
(785 |
) |
|
|
(1,368 |
) |
|
|
(1,593 |
) |
Other income (expense), net |
|
6 |
|
|
|
(246 |
) |
|
|
(210 |
) |
|
|
(43 |
) |
Total other income (expense) |
|
(613 |
) |
|
|
(1,031 |
) |
|
|
(1,578 |
) |
|
|
(1,636 |
) |
Income before income
taxes |
|
2,419 |
|
|
|
2,059 |
|
|
|
4,125 |
|
|
|
9,219 |
|
Income tax expense |
|
(819 |
) |
|
|
(587 |
) |
|
|
(1,459 |
) |
|
|
(3,031 |
) |
Net income |
$ |
1,600 |
|
|
$ |
1,472 |
|
|
$ |
2,666 |
|
|
$ |
6,188 |
|
Net income per share: |
|
|
|
|
|
|
|
Basic |
$ |
0.12 |
|
|
$ |
0.11 |
|
|
$ |
0.19 |
|
|
$ |
0.44 |
|
Diluted |
$ |
0.11 |
|
|
$ |
0.10 |
|
|
$ |
0.19 |
|
|
$ |
0.43 |
|
Weighted average shares
outstanding: |
|
|
|
|
|
|
|
Basic |
|
13,718 |
|
|
|
13,956 |
|
|
|
13,714 |
|
|
|
14,089 |
|
Diluted |
|
14,016 |
|
|
|
14,388 |
|
|
|
13,952 |
|
|
|
14,523 |
|
|
|
|
|
|
|
|
|
Other
comprehensive income (loss), net of tax: |
|
|
|
|
|
|
|
Foreign currency translation
adjustment |
|
9 |
|
|
|
(136 |
) |
|
|
26 |
|
|
|
(79 |
) |
Other comprehensive income
(loss), net of tax: |
|
9 |
|
|
|
(136 |
) |
|
|
26 |
|
|
|
(79 |
) |
Comprehensive income |
$ |
1,609 |
|
|
$ |
1,336 |
|
|
$ |
2,692 |
|
|
$ |
6,109 |
|
|
|
|
|
|
|
|
|
LIFEVANTAGE CORPORATION AND
SUBSIDIARIES |
|
Revenue by Region |
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
December 31, |
|
For the Six Months Ended
December 31, |
|
|
|
|
2015 |
|
|
|
2014 |
|
|
|
2015 |
|
|
|
2014 |
|
|
(In thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas |
|
$ |
40,055 |
|
|
|
77 |
% |
|
$ |
35,040 |
|
|
|
73 |
% |
|
$ |
74,781 |
|
|
|
77 |
% |
|
$ |
71,496 |
|
|
|
72 |
% |
|
Asia/Pacific |
|
|
11,940 |
|
|
|
23 |
% |
|
|
13,207 |
|
|
|
27 |
% |
|
|
22,566 |
|
|
|
23 |
% |
|
|
28,384 |
|
|
|
28 |
% |
|
Total |
|
$ |
51,995 |
|
|
|
100 |
% |
|
$ |
48,247 |
|
|
|
100 |
% |
|
$ |
97,347 |
|
|
|
100 |
% |
|
$ |
99,880 |
|
|
|
100 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Active Independent Distributors
(1) |
|
|
|
|
|
|
|
|
|
|
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
Americas |
|
|
46,000 |
|
|
|
69 |
% |
|
|
44,000 |
|
|
|
66 |
% |
|
|
|
|
|
|
|
|
|
Asia/Pacific |
|
|
21,000 |
|
|
|
31 |
% |
|
|
23,000 |
|
|
|
34 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
67,000 |
|
|
|
100 |
% |
|
|
67,000 |
|
|
|
100 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Active Preferred
Customers(2) |
|
|
|
|
|
|
|
|
|
|
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
Americas |
|
|
96,000 |
|
|
|
82 |
% |
|
|
97,000 |
|
|
|
82 |
% |
|
|
|
|
|
|
|
|
|
Asia/Pacific |
|
|
21,000 |
|
|
|
18 |
% |
|
|
22,000 |
|
|
|
18 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
117,000 |
|
|
|
100 |
% |
|
|
119,000 |
|
|
|
100 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Active Independent Distributors have purchased
product in the prior three months for retail or personal
consumption. |
|
(2) Active Preferred Customers have purchased product in
the prior three months for personal consumption only. |
|
LIFEVANTAGE CORPORATION AND
SUBSIDIARIES |
|
Reconciliation of GAAP Net Income to Non-GAAP
EBITDA and Non-GAAP Adjusted EBITDA: (Unaudited) |
|
|
|
|
|
|
|
|
For the Three Months Ended December
31, |
|
For the Six Months Ended December
31, |
|
|
|
2015 |
|
|
|
2014 |
|
|
|
2015 |
|
|
|
2014 |
|
|
(In thousands) |
|
|
|
|
|
|
|
|
GAAP Net income |
$ |
1,600 |
|
|
$ |
1,472 |
|
|
$ |
2,666 |
|
|
$ |
6,188 |
|
|
Interest Expense |
|
619 |
|
|
|
785 |
|
|
|
1,368 |
|
|
|
1,593 |
|
|
Provision for income
taxes |
|
819 |
|
|
|
587 |
|
|
|
1,459 |
|
|
|
3,031 |
|
|
Depreciation and
amortization |
|
452 |
|
|
|
580 |
|
|
|
983 |
|
|
|
1,165 |
|
|
Non-GAAP EBITDA: |
|
3,490 |
|
|
|
3,424 |
|
|
|
6,476 |
|
|
|
11,977 |
|
|
Adjustments: |
|
|
|
|
|
|
|
|
Stock compensation
expense |
|
450 |
|
|
|
495 |
|
|
|
642 |
|
|
|
969 |
|
|
Other (income) expense,
net |
|
(6 |
) |
|
|
246 |
|
|
|
210 |
|
|
|
43 |
|
|
Other adjustments* |
|
535 |
|
|
|
- |
|
|
|
1,614 |
|
|
|
(2,000 |
) |
|
Total adjustments |
|
979 |
|
|
|
741 |
|
|
|
2,466 |
|
|
|
(988 |
) |
|
Non-GAAP Adjusted
EBITDA |
$ |
4,469 |
|
|
$ |
4,165 |
|
|
$ |
8,942 |
|
|
$ |
10,989 |
|
|
|
|
|
|
|
|
*Other adjustments for the six months ended December 31, 2015
include approximately $0.7 million for executive severance
expenses, $0.8 million for search firm and hiring expenses
associated with the search for executive officers, and $0.1 million
for expenses associated with the reverse stock split completed
during October 2015. Other adjustments for the six months
ended December 30, 2014 include a ($2.0) million reduction for a
one-time pretax benefit from settlement proceeds. Other
adjustments for the three months ended December 31, 2015 include
approximately $0.4 million for search firm and hiring expenses
associated with the search for executive officers and $0.1 million
for expenses associated with the reverse stock split completed
during October 2015. |
|
|
|
|
|
|
|
|
|
|
LIFEVANTAGE CORPORATION AND
SUBSIDIARIES |
Reconciliation of GAAP Net Income to Non-GAAP
Net Income and Non-GAAP Adjusted EPS: (Unaudited) |
|
|
|
|
|
|
|
For the Three Months Ended December
31, |
|
For the Six Months Ended December
31, |
|
|
2015 |
|
|
|
2014 |
|
|
|
2015 |
|
|
|
2014 |
|
(In thousands) |
|
|
|
|
|
|
|
GAAP Net income |
$ |
1,600 |
|
|
$ |
1,472 |
|
|
$ |
2,666 |
|
|
$ |
6,188 |
|
Executive team
severance expenses (1) |
|
- |
|
|
|
- |
|
|
|
438 |
|
|
|
- |
|
Executive team
recruiting and transition expenses(2) |
|
243 |
|
|
|
- |
|
|
|
503 |
|
|
|
- |
|
Reverse split
administrative expenses(3) |
|
103 |
|
|
|
- |
|
|
|
103 |
|
|
|
- |
|
Insurance proceeds from
product recall(4) |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,342 |
) |
Non-GAAP Net
Income: |
|
1,946 |
|
|
|
1,472 |
|
|
|
3,710 |
|
|
|
4,846 |
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended December
31, |
|
For the Six Months Ended December
31, |
|
|
2015 |
|
|
|
2014 |
|
|
|
2015 |
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
Diluted earnings per
share, as reported |
$ |
0.11 |
|
|
$ |
0.10 |
|
|
$ |
0.19 |
|
|
$ |
0.43 |
|
Executive team
severance expenses (1) |
|
- |
|
|
|
- |
|
|
|
0.03 |
|
|
|
- |
|
Executive team
recruiting and transition expenses(2) |
|
0.02 |
|
|
|
- |
|
|
|
0.04 |
|
|
|
- |
|
Reverse split
administrative expenses(3) |
|
0.01 |
|
|
|
- |
|
|
|
0.01 |
|
|
|
- |
|
Insurance proceeds from
product recall(4) |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(0.09 |
) |
Diluted earnings per
share, as adjusted |
$ |
0.14 |
|
|
$ |
0.10 |
|
|
$ |
0.27 |
|
|
$ |
0.34 |
|
|
|
|
|
|
|
(1) Net of $239,000 tax expense for the six months ended
December 31, 2015 |
(2) Net of $133,000 and $275,000 tax expense for the three and
six months ended December 31, 2015, respectively |
(3) Net of $56,000 tax expense for the three and six months
ended December 31, 2015 |
(4) Net of $658,000 tax expense for the six months ended
December 31, 2014 |
Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (646) 277-1254
Partner, ICR INC
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Sep 2023 to Sep 2024